Severe Acute Respiratory Syndrome Coronavirus 2 Placental Infection and Inflammation Leading to Fetal Distress and Neonatal Multi-Organ Failure in an Asymptomatic Woman.
Adult
COVID-19
/ transmission
Cesarean Section
Female
Fetal Distress
/ virology
Humans
Infant, Newborn
Infant, Premature
Infectious Disease Transmission, Vertical
Multiple Organ Failure
/ virology
Placenta
/ virology
Pneumonia, Viral
/ transmission
Pregnancy
Pregnancy Complications, Infectious
/ virology
SARS-CoV-2
Kawasaki-like syndrome
SARS-CoV-2
fetal distress
inflammation
placenta
Journal
Journal of the Pediatric Infectious Diseases Society
ISSN: 2048-7207
Titre abrégé: J Pediatric Infect Dis Soc
Pays: England
ID NLM: 101586049
Informations de publication
Date de publication:
28 May 2021
28 May 2021
Historique:
received:
22
07
2020
accepted:
23
11
2020
pubmed:
29
12
2020
medline:
4
6
2021
entrez:
28
12
2020
Statut:
ppublish
Résumé
In general, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy is not considered to be an increased risk for severe maternal outcomes but has been associated with an increased risk for fetal distress. Maternal-fetal transmission of SARS-CoV-2 was initially deemed uncertain; however, recently a few cases of vertical transmission have been reported. The intrauterine mechanisms, besides direct vertical transmission, leading to the perinatal adverse outcomes are not well understood. Multiple maternal, placental, and neonatal swabs were collected for the detection of SARS-CoV-2 using real-time quantitative polymerase chain reaction (RT-qPCR). Serology of immunoglobulins against SARS-CoV-2 was tested in maternal, umbilical cord, and neonatal blood. Placental examination included immunohistochemical investigation against SARS-CoV-2 antigen expression, with SARS-CoV-2 ribonucleic acid (RNA) in situ hybridization and transmission electron microscopy. RT-qPCRs of the oropharynx, maternal blood, vagina, placenta, and urine were all positive over a period of 6 days, while breast milk, feces, and all neonatal samples tested negative. Placental findings showed the presence of SARS-CoV-2 particles with generalized inflammation characterized by histiocytic intervillositis with diffuse perivillous fibrin depositions with damage to the syncytiotrophoblasts. Placental infection by SARS-CoV-2 leads to fibrin depositions hampering fetal-maternal gas exchange with resulting fetal distress necessitating a premature emergency cesarean section. Postpartum, the neonate showed a fetal or pediatric inflammatory multisystem-like syndrome with coronary artery ectasia temporarily associated with SARS-CoV-2 for which admittance and care on the neonatal intensive care unit (NICU) were required, despite being negative for SARS-CoV-2. This highlights the need for awareness of adverse fetal and neonatal outcomes during the current coronavirus disease 2019 pandemic, especially considering that the majority of pregnant women appear asymptomatic.
Sections du résumé
BACKGROUND
BACKGROUND
In general, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy is not considered to be an increased risk for severe maternal outcomes but has been associated with an increased risk for fetal distress. Maternal-fetal transmission of SARS-CoV-2 was initially deemed uncertain; however, recently a few cases of vertical transmission have been reported. The intrauterine mechanisms, besides direct vertical transmission, leading to the perinatal adverse outcomes are not well understood.
METHODS
METHODS
Multiple maternal, placental, and neonatal swabs were collected for the detection of SARS-CoV-2 using real-time quantitative polymerase chain reaction (RT-qPCR). Serology of immunoglobulins against SARS-CoV-2 was tested in maternal, umbilical cord, and neonatal blood. Placental examination included immunohistochemical investigation against SARS-CoV-2 antigen expression, with SARS-CoV-2 ribonucleic acid (RNA) in situ hybridization and transmission electron microscopy.
RESULTS
RESULTS
RT-qPCRs of the oropharynx, maternal blood, vagina, placenta, and urine were all positive over a period of 6 days, while breast milk, feces, and all neonatal samples tested negative. Placental findings showed the presence of SARS-CoV-2 particles with generalized inflammation characterized by histiocytic intervillositis with diffuse perivillous fibrin depositions with damage to the syncytiotrophoblasts.
CONCLUSIONS
CONCLUSIONS
Placental infection by SARS-CoV-2 leads to fibrin depositions hampering fetal-maternal gas exchange with resulting fetal distress necessitating a premature emergency cesarean section. Postpartum, the neonate showed a fetal or pediatric inflammatory multisystem-like syndrome with coronary artery ectasia temporarily associated with SARS-CoV-2 for which admittance and care on the neonatal intensive care unit (NICU) were required, despite being negative for SARS-CoV-2. This highlights the need for awareness of adverse fetal and neonatal outcomes during the current coronavirus disease 2019 pandemic, especially considering that the majority of pregnant women appear asymptomatic.
Identifiants
pubmed: 33367801
pii: 6053141
doi: 10.1093/jpids/piaa153
pmc: PMC7798999
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
556-561Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society.
Références
PLoS One. 2020 Apr 16;15(4):e0230295
pubmed: 32298273
Annu Rev Virol. 2018 Sep 29;5(1):273-299
pubmed: 30048217
Am J Obstet Gynecol. 2021 Apr;224(4):382.e1-382.e18
pubmed: 33091406
JAMA. 2020 Jun 2;323(21):2198-2200
pubmed: 32352491
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
Helv Paediatr Acta. 1981;36(6):589-98
pubmed: 6120921
Am J Obstet Gynecol. 2021 Jan;224(1):35-53.e3
pubmed: 32739398
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
Ann Rheum Dis. 2019 Feb;78(2):289-290
pubmed: 30282667
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Cytokine. 2019 Jul;119:52-56
pubmed: 30877950
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100135
pubmed: 32391520
Pathology. 2006 Jun;38(3):210-8
pubmed: 16753741
Eur J Obstet Gynecol Reprod Biol. 2009 Mar;143(1):9-13
pubmed: 19121887
Am J Obstet Gynecol. 2020 Aug;223(2):275-278
pubmed: 32405074
J Clin Invest. 2020 Sep 1;130(9):4947-4953
pubmed: 32573498
J Neonatal Perinatal Med. 2013;6(3):263-6
pubmed: 24246600
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Clin Obstet Gynecol. 2007 Sep;50(3):652-83
pubmed: 17762416
J Matern Fetal Neonatal Med. 2022 Apr;35(8):1619-1622
pubmed: 32354293
Arch Pathol Lab Med. 2020 Dec 1;144(12):1451-1456
pubmed: 32886737
Nat Commun. 2020 Jul 14;11(1):3572
pubmed: 32665677
Expert Rev Clin Immunol. 2017 Mar;13(3):247-258
pubmed: 27590181
Pediatr Rheumatol Online J. 2018 Jul 3;16(1):43
pubmed: 29970110
Pediatr Cardiol. 2016 Aug;37(6):1148-52
pubmed: 27233663
Placenta. 2010 Dec;31(12):1106-10
pubmed: 21035849
Ultrasound Obstet Gynecol. 1997 Mar;9(3):162-72
pubmed: 9165679
JAMA Pediatr. 2020 Oct 1;174(10):1004-1005
pubmed: 32687557
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
N Engl J Med. 2020 May 28;382(22):2163-2164
pubmed: 32283004
Nat Commun. 2020 Oct 12;11(1):5128
pubmed: 33046695
Placenta. 2020 Nov;101:13-29
pubmed: 32911234
N Engl J Med. 2016 Sep 8;375(10):1002-4
pubmed: 27463941